Midkine (Human, 60-121)

Ala-Asp-Cys-Lys-Tyr-Lys-Phe-Glu-Asn-Trp-Gly-Ala-Cys-Asp-Gly-Gly-Thr-Gly-Thr-Lys-Val-Arg-Gln-Gly-Thr-Leu-Lys-Lys-Ala-Arg-Tyr-Asn-Ala-Gln-Cys-Gln-Glu-Thr-Ile-Arg-Val-Thr-Lys-Pro-Cys-Thr-Pro-Lys-Thr-Lys-Ala-Lys-Ala-Lys-Ala-Lys-Lys-Gly-Lys-Gly-Lys-Asp (Disulfide bonds between Cys⁶²-Cys⁹⁴ and Cys⁷²-Cys¹⁰⁴)
: (M.W. 6788.8) C₂₉₂H₄₈₃N₉₁O₈₇S₄
: Heparin-Binding Growth/Differentiation Factor Active-Domain
(Neurite Outgrowth-Promoting Factor)
Plasminogen Activator Activity Enhancer

Package	Price(Yen)	Availability	Quantity
Vial 0.1 mg	30,000	Ships within 1-3 business days
バルク見積もり

Solubility: H₂O (0.1 mM)

J-i. Tsutsui, K. Uehara, K. Kadomatsu, S. Matsubara, and T. Muramatsu, Biochem. Biophys. Res. Commun., 176, 792 (1991). (Original)
H. Muramatsu, T. Inui, T. Kimura, S. Sakakibara, X.-j. Song, H. Maruta, and T. Muramatsu, Biochem. Biophys. Res. Commun., 203, 1131 (1994). (Pharmacol.)
T. Inui, J. Bódi, S. Kubo, H. Nishio, T. Kimura, S.Kojima, H. Maruta, T. Muramatsu, and S. Sakakibara, J. Peptide Sci., 2, 28 (1996). (Chem. Synthesis)
G.S.P. Yu, J. Hu, and H. Nakagawa, Neurosci. Lett., 254, 128 (1998). (Pharmacol.; Inhibition of β-amyloid cytotoxicity)